Numerous instances of complementary mergers exist, including the merger of Luxottica and Essilor and the unsuccessful acquisition of Grail by Illumina. These mergers typically involve companies offering complementary products, such as eyewear frames and lenses or gene sequencing platforms and cancer diagnostics. Additionally, other market characteristics, such as the retail market dynamics in the Luxottica and Essilor merger and the innovation markets in the Illumina and Grail case, introduce further complexities.
Keep reading with a 7-day free trial
Subscribe to econworks to keep reading this post and get 7 days of free access to the full post archives.